Integrating intracranial hypofractionated radiotherapy with immunotherapy for melanoma brain metastases: therapeutic impact and immune modulation
Therapeutic Advances in Medical Oncology
Published online on April 26, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Combined radiotherapy and immunotherapy can enhance antitumor efficacy, but its effects on melanoma brain metastases (MBM) remain unclear.Objectives:To evaluate the intracranial efficacy, safety, and exploratory immune biomarkers of ...
Background:Combined radiotherapy and immunotherapy can enhance antitumor efficacy, but its effects on melanoma brain metastases (MBM) remain unclear.Objectives:To evaluate the intracranial efficacy, safety, and exploratory immune biomarkers of ...